Mitsubishi Tanabe Plans Japan Trial for Plant-Derived COVID-19 Vaccine from October

September 30, 2021
Mitsubishi Tanabe Pharma plans to begin a clinical trial in Japan for Canadian subsidiary Medicago’s COVID-19 vaccine from October, aiming for its regulatory submission in the country next March, company officials revealed on September 29. The vaccine is being investigated...read more